Halcyon Organics Medical Cannabis, MMJ, Marijuana, Georgia, Florida, California, Colorado

Clinical Endocannabinoid System Deficiency

The Human Endocannabinoid System

Our bodies have an endogenous series of receptors designed to synthesize and utilize cannabinoids called the human endocannabinoid system (ECS).  The ECS, not discovered until the 1990’s, is an exciting scientific and medical discovery.  Because research is still in infancy, we are only beginning to learn what this important endogenous system does.

The ECS is a network of receptors that control some of our most vital life functions, including our immune system, memory, appetite, sleep pattern, and pain sensation.  The receptors that we are certain make up the endocannabinoid system are CB (cannabinoid) 1 and 2, TRPV (Transient Receptor Potential Vanilloid) 1 and 2, and some GPR (G coupled protein receptor).  These receptors are spread throughout our entire body, but seem to be mostly concentrated in our brains, central nervous systems, bones, and other organs.

Cannabinoid ligands agonize and antagonize the ECS receptors.  The human body naturally produces two endogenous cannabinoid ligands, anandamide (AEA) and 2-archidon0ylglycerol (2-AG).  Ligands are compounds that stimulate receptors.  A healthy endocannabinoid system creates homeostasis in the human body.  Inversely, if your endocannabinoid system is out of whack, you will have health problems.

Clinical Endocannabinoid Deficiency (CECD)

We recently learned that a host of common medical conditions are linked to endocannabinoid deficiency.  The condition is known as Clinical Endocannabinoid Deficiency (CECD).  Scientists have found that deficiencies of AEA and 2-AG are consistent with people who suffer from migraines, irritable bowel syndrome, and fibromyalgia.

What this means is that if your body isn’t producing enough cannabinoids, you will probably suffer from severe headaches, neuropathic pain and stomach problems.  People who suffer from the above mentioned conditions who use cannabis already know that cannabis treats nearly all of the associated symptoms. People who suffer from endocannabinoid deficiencies who don’t use cannabis just have to suffer or use less effective and more toxic medications.

Before I learned about cannabis’ medicinal properties, I’d hear recreational marijuana users say, “weed makes my IBS better” or “smoking pot is the only thing that fixes a migraine”.  I’ve had dozen of clients who suffer from Crohn’s disease swear that cannabis was a miracle remedy.  I would respond with an obligatory “that’s really awesome!  I’m glad that I’m helping you!”, all the while thinking to myself, “Whatever, man. Why don’t you just say you like smoking pot and own it instead of justifying it with pretend medical problem?”

Well, it turns out that they were right about cannabis helping them and I’m just a jerk.  In order to atone for my cynicism, we’re developing cannabis based dietary supplements to treat clinical endocannabinoid deficiency.  The nutraceuticals will treat the pain and inflammation associated with anandamide deficiency.  This includes migraines, fibromyalgia and irritable bowel syndrome.  We will have both psychoactive and non-psychoactive formulas for different state laws and age groups.

By: Daniel Macris, founder and ceo of Halcyon Organics.

© 2015 Halcyon Organics

Originally published  Jul 6, 2014 @ 21:06

3 replies

Trackbacks & Pingbacks

  1. […] needs cannabinoids to function properly.  Due to cannabis prohibition, most Americans suffer from endocannabinoid deficiency syndrome.  Endocannabinoid deficiencies manifest themselves in the form of autoimmune diseases, depression, […]

  2. […] needs cannabinoids to function properly.  Due to cannabis prohibition, most Americans suffer from endocannabinoid deficiency syndrome.  Endocannabinoid deficiencies manifest themselves in the form of autoimmune diseases, depression, […]

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *